Poor Survival Outcomes of Checkpoint Inhibitors for B-Cell Lymphomas Relapsing after or Refractory to CAR T-Cell Therapy: A Real-World Cohort from 15 U.S. Academic Institutions

Subjects

Subjects :

Immunology
Cell Biology
Hematology
Biochemistry

Details

ISSN :

15280020 and 00064971

Volume :

140

Database :

OpenAIRE

Journal :

Blood

Accession number :

edsair.doi...........9dd21cab171f68ea4052fe7440b870b3

Full Text :

https://doi.org/10.1182/blood-2022-157829